Related Experiment Video
Updated: Feb 24, 2026

Author Spotlight: Optimizing EAS with Long Electrodes for Enhanced Cochlear Coverage and Hearing Preservation
Published on: October 11, 2024
CADASIL or CADVaSIL?
Janina Rafalowska1, Anna Fidzianska, Dorota Dziewulska
1Department of Neuropathology, Medical Research Center, Polish Academy of Sciences, Medical University of Warsaw, Warsaw, Poland. ddziewul@amwaw.edu.pl
Morphological studies reveal that cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) affects small vessels beyond the brain. This suggests the disease is systemic, impacting internal organs and capillaries.
Area of Science:
- Neurology
- Pathology
- Genetics
Background:
- Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a rare genetic disorder.
- It primarily affects cerebral blood vessels, leading to stroke and cognitive decline.
Purpose of the Study:
- To investigate the full morphological spectrum of CADASIL.
- To determine if the disease affects vessels beyond the brain and small cerebral vessels.
Main Methods:
- Light and electron microscopy were used to examine blood vessels from two Polish families with CADASIL.
- Vessels from the brain and internal organs were analyzed.
Main Results:
- Characteristic pathological changes were observed in cerebral arteries and veins.
- Granular osmiophilic material (GOM) deposits were found in cerebral capillaries and vessels of internal organs.
- These deposits occurred in vessels lacking smooth muscle cells.
Conclusions:
- The pathological process in CADASIL is generalized, affecting small vessels throughout the body, including capillaries.
- The findings support a broader understanding of CADASIL pathology beyond large cerebral arteries.
- A name change, such as cerebral autosomal dominant vasculopathy with subcortical infarcts and leukoencephalopathy (CADVaSIL), is proposed to better reflect the disease's morphology.
Related Concept Videos
Oral Drug Delivery Systems: Continuous-Release Systems
Dosage Regimen: Multiple Oral Dosage
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

